Contact this trialFirst, we need to learn more about you.
Nicotinic Acetylcholine Receptor Partial Agonist
Varenicline for Nicotine Addiction
Recruiting5 awardsPhase 4
La Jolla, California
This trial is testing whether a lower dose and slower titration schedule of varenicline, combined with behavioral treatment, is feasible for smokers with bipolar disorder, schizophrenia or schizoaffective disorder who are motivated to quit.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.